Emboldened In Court, Lupin Launches First US Oracea Generic At Risk
Originator Galderma Has Filed An Appeal, Seeks Injunctive Relief
Lupin has shown its confidence in its legal position after introducing the first US generic version of Galderma’s rosacea treatment, Oracea, while the originator battles for injunctive relief.
